{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:42:13Z","timestamp":1787582533936,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.humpath.2025.105766","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:38:38Z","timestamp":1744303118000},"page":"105766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-5912","authenticated-orcid":false,"given":"Hanan","family":"Hamdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Siddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Ramia de Cap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel D.","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Fuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Vandergriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga K.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105766_bib1","series-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","first-page":"145","article-title":"Blastic plasmacytoid dendritic cell neoplasm","author":"Facchetti","year":"2008"},{"key":"10.1016\/j.humpath.2025.105766_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.humpath.2025.105766_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2025.105766_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood.2020008211","article-title":"How I diagnose and treat NPM1-mutated AML","volume":"137","author":"Falini","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2025.105766_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3324\/haematol.2009.017822","article-title":"Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help","volume":"95","author":"Falini","year":"2010","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.humpath.2025.105766_bib6","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1182\/blood.2021012732","article-title":"Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML","volume":"138","author":"Martelli","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105766_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.leukres.2006.03.013","article-title":"NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype","volume":"31","author":"Zhang","year":"2007","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.humpath.2025.105766_bib8","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1002\/ajh.24861","article-title":"Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance","volume":"92","author":"Vallapureddy","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.humpath.2025.105766_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/bloodadvances.2018026989","article-title":"NPM1 mutations define a specific subgroup of MDS and MDS\/MPN patients with favorable outcomes with intensive chemotherapy","volume":"3","author":"Montalban-Bravo","year":"2019","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.humpath.2025.105766_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/bloodadvances.2019000090","article-title":"Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms","volume":"3","author":"Patel","year":"2019","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.humpath.2025.105766_bib11","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.3390\/ijms21238975","article-title":"NPM1-Mutated myeloid neoplasms with <20% blasts: a really distinct clinico-pathologic entity?","volume":"21","author":"Forghieri","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.humpath.2025.105766_bib12","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/10428194.2023.2185091","article-title":"Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group","volume":"64","author":"Cap","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"10.1016\/j.humpath.2025.105766_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105766_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2025.105766_bib19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","article-title":"TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow","volume":"88","author":"Alayed","year":"2013","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.humpath.2025.105766_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-20-1513","article-title":"Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis","volume":"12","author":"Togami","year":"2022","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.humpath.2025.105766_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Menezes","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2025.105766_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3324\/haematol.13855","article-title":"Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm","volume":"94","author":"Facchetti","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.humpath.2025.105766_bib23","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1002\/ajh.24956","article-title":"A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis","volume":"93","author":"Minetto","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2025.105766_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Menezes","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2025.105766_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2013-05-500413","article-title":"BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells","volume":"122","author":"Boiocchi","year":"2013","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.humpath.2025.105766_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.2021011817","article-title":"Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm","volume":"138","author":"Pemmaraju","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2025.105766_bib17","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.18632\/oncotarget.7101","article-title":"Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy","volume":"7","author":"Mart\u00edn-Mart\u00edn","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2025.105766_bib24","series-title":"StatPearls","article-title":"Blastic plasmacytoid dendritic cell neoplasm","author":"Singh","year":"2024"},{"issue":"16","key":"10.1016\/j.humpath.2025.105766_bib25","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/cncr.34345","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a promising future in the era of targeted therapeutics","volume":"128","author":"Adimora","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.105766_bib26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/s41375-023-01968-z","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies","volume":"37","author":"Cuglievan","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.105766_bib27","series-title":"Leukemia cutis. Treasure island (FL)","author":"Parsi","year":"2024"},{"issue":"10","key":"10.1016\/j.humpath.2025.105766_bib18","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.3324\/haematol.2015.129346","article-title":"NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features","volume":"100","author":"Luskin","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.humpath.2025.105766_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5144\/0256-4947.2013.539","article-title":"A surrogate marker to detect nucleophosnim (NPM1) gene mutations in the cytoplasm of acute myeloid leukemia (AML) blast cells in 30 adult Iraqi patients","volume":"33","author":"Al-Husseinawi","year":"2013","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.humpath.2025.105766_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.701318","article-title":"Comparison of multiple clinical testing modalities for assessment of NPM1-mutant AML","volume":"11","author":"Lopez","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2025.105766_bib29","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1038\/s41598-022-10831-7","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.humpath.2025.105766_bib30","first-page":"236","article-title":"Biallelic TET2 mutations and canonical ASXL1 mutations are frequent and cooccur in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): an institutional experience and review of literature","volume":"4","author":"Zhang","year":"2023","journal-title":"EJH"},{"issue":"23","key":"10.1016\/j.humpath.2025.105766_bib31","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.3390\/cancers13235888","article-title":"Integrated clinical genotype-phenotype characteristics of blastic plasmacytoid dendritic cell neoplasm","volume":"13","author":"Yin","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:14:47Z","timestamp":1748006087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"alternative-id":["S004681772500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105766","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105766"}}